Evidence map›Paper›PMID 24658133›Full record

ArticleOncotarget2014

p63 transcriptionally regulates the expression of matrix metallopeptidase 13.

Ivana Celardo, Alexey Antonov, Ivano Amelio, Margherita Annicchiarico-Petruzzelli, Gerry Melino

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Cancer predictive studies.Biology direct · 2020
    Review
  6. Article
  7. p63 at the Crossroads between Stemness and Metastasis in Breast Cancer.International journal of molecular sciences · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TAp73 transcriptionally represses BNIP3 expression.Cell cycle (Georgetown, Tex.) · 2015
    Article
  15. Article
  16. Review
  17. Review
  18. TAp73 promotes anabolism.Oncotarget · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Ivana CelardoMedical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK.
Alexey Antonov
Ivano Amelio
Margherita Annicchiarico-Petruzzelli
Gerry Melino
Medical Research Council · GBIstituto Dermopatico dell'Immacolata · ITUniversity of Leicester · GBUniversity of Rome Tor Vergata · IT

Funding

Medical Research Council MC_U132670600
6 · The paper itself

Abstract

p63 is a transcriptional factor belonging to p53 family of genes. Beside the role in cancer, partially shared with p53 and the other member p73, p63 also plays exclusive roles in development and homeostasis of ectodermal/epidermal-related organs. Here we show that p63 transcriptionally controls the expression of the matrix metallopeptidase 13 (MMP13). p63 binds a p53-like responsive element in the human promoter of MMP13, thus promoting the activation of its transcription. The catalytic activity of MMP13 is required in high invasion capacity of metastatic cancer cells, however, although p63 and MMP13 expression correlates in cancer patients, their co-expression does not predict cancer patient survival. Our results demonstrate that p63 directly controls MMP13 expression.

Indexed as

Gene Expression RegulationTranscription, GeneticBreast NeoplasmsCell LineHumansKaplan-Meier EstimateMatrix Metalloproteinase 13MelanomaOligonucleotide Array Sequence AnalysisPromoter Regions, GeneticRNA, MessengerTranscription FactorsTumor Suppressor ProteinsMatrix Metalloproteinase 13RNA, MessengerTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID24658133
PMCPMC4012734
OpenAlexW2146902391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.